Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Long-term Outcomes of Peripheral Blood Stem Cell Unrelated Donors Mobilized with Filgrastim.
Blood Adv. 2024 Apr 30:bloodadvances.2024012646. doi: 10.1182/bloodadvances.2024012646. Online ahead of print.
Blood Adv. 2024.
PMID: 38687368
Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union.
Wyrwicz L, Rodríguez Sánchez CA, Sánchez-Rovira P, Lewis S, Sandschafer D, San T.
Wyrwicz L, et al. Among authors: sandschafer d.
Future Oncol. 2024 Apr;20(13):821-832. doi: 10.2217/fon-2023-0421. Epub 2024 Feb 2.
Future Oncol. 2024.
PMID: 38305004
Free article.
Item in Clipboard
Real-world outcomes among patients with metastatic colorectal cancer treated first line with a bevacizumab biosimilar (bevacizumab-awwb).
Jin R, Ogbomo AS, Accortt NA, Lal LS, Bishi G, Sandschafer D, Goldschmidt JH.
Jin R, et al. Among authors: sandschafer d.
Ther Adv Med Oncol. 2023 Jun 21;15:17588359231182386. doi: 10.1177/17588359231182386. eCollection 2023.
Ther Adv Med Oncol. 2023.
PMID: 37360769
Free PMC article.
Item in Clipboard
Two decades of pegfilgrastim: what have we learned? Where do we go from here?
De Oliveira Brandao C, Lewis S, Sandschafer D, Crawford J.
De Oliveira Brandao C, et al. Among authors: sandschafer d.
Curr Med Res Opin. 2023 May;39(5):707-718. doi: 10.1080/03007995.2023.2196197. Epub 2023 Apr 8.
Curr Med Res Opin. 2023.
PMID: 36976784
Review.
Item in Clipboard
Clinical and treatment characteristics of patients treated with the first therapeutic oncology biosimilars bevacizumab-awwb and trastuzumab-anns in the US.
Jin R, Mahtani RL, Accortt N, Lawrence T, Sandschafer D, Loaiza-Bonilla A.
Jin R, et al. Among authors: sandschafer d.
Ther Adv Med Oncol. 2021 Sep 1;13:17588359211041961. doi: 10.1177/17588359211041961. eCollection 2021.
Ther Adv Med Oncol. 2021.
PMID: 35003333
Free PMC article.
Item in Clipboard
Real-world use of bevacizumab-awwb, a bevacizumab biosimilar, in US patients with metastatic colorectal cancer.
Rhodes W, DeClue RW, Accortt NA, Jin R, Sandschafer D, Wertz D, Patel K.
Rhodes W, et al. Among authors: sandschafer d.
Future Oncol. 2021 Dec;17(36):5119-5127. doi: 10.2217/fon-2021-0588. Epub 2021 Oct 26.
Future Oncol. 2021.
PMID: 34698523
Free article.
Item in Clipboard
Cite
Cite